Qualify For HIFU - Prostate Cancer Treatment

Non-invasive Prostate Cancer Treatment with Ablatherm HIFU
at Cleveland Clinic Canada

Maple Leaf HIFU is proud to have been the first North American provider of Ablatherm High Intensity Focused Ultrasound (HIFU) for the treatment of localized prostate cancer. We are the most experienced HIFU treatment clinic in North America. Our staff consists of top urologists, trained in the United States, Europe and Canada.

Our non-invasive prostate cancer treatment is available at Maple Leaf HIFU located at Cleveland Clinic Canada. Cleveland Clinic Canada, the Canadian location of the renowned Cleveland Clinic, is an outpatient facility that specializes in disease prevention, early detection and sports medicine. Our clinic uses the Ablatherm HIFU for the best accuracy and results.

To determine if you might be a candidate, we request information related to your condition. Please provide the following information (if available) and we will quickly respond. Alternatively, send us an e-mail to info@hifu.ca . To learn more, continue reading about the procedure.

Learn about HIFU Focal Therapy


First Name:
Last Name:
Your age:

(please include area code)
Email address:
Cancer stage:

Gleason score:

Volume recorded on
transrectal ultrasound
(prostate size):

Have you been treated for prostate cancer in the past?
Yes No
If yes, how was your prostate cancer previously treated?

General comments:

We're sorry - but we need to make sure you're not a spam robot!

Questions about the form or information required?
Please call Maple Leaf HIFU at 877 370 4438 for assistance. Our highly trained registered nurses will assist you through the process – from inquiry to post-treatment follow up. Ablatherm HIFU is an outpatient procedure that does not involve surgery and takes approximately two hours.

HIFU is FDA approved and Health Canada approved. Over 40,000 patients worldwide have been treated with HIFU and  our number are increasing monthly. Some medical insurance companies may cover the procedure.